Bulletin: Kardium raises $115M in new financing
Fidelity Management & Research Company LLC and T. Rowe Price funds lead private financing round
Vancouver-based Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by T. Rowe Price Associates, Inc.
The new fina…